Predictive Markers for mCRC

preview_player
Показать описание
Experts share insight on which predictive biomarkers are being tested for in metastatic colorectal cancer and elucidate testing methods.

  1. OncLive
  2. cancer
  3. oncology
Рекомендации по теме
Predictive Markers for 0:03:33

Predictive Markers for mCRC

Tumor Location Prognostic 0:06:14

Tumor Location Prognostic or Predictive Marker in Metastatic Colorectal Cancer

Evaluating predictive markers 0:17:13

Evaluating predictive markers and subgroups in clinical trials: Caution and best practices

Immunotherapy Combinations in 0:04:00

Immunotherapy Combinations in MSI and MSS mCRC

BRAF-Mutated mCRC: From 1:35:47

BRAF-Mutated mCRC: From Diagnosis to Treatment

Key Investigations in 0:01:56

Key Investigations in Advanced Colorectal Cancer

Dr. Morris on 0:01:13

Dr. Morris on the Design of the COBRA Trial in Stage II Colon Cancer

Adding chemotherapy to 0:03:35

Adding chemotherapy to immunotherapy in metastatic CRC

Trial results of 0:02:02

Trial results of vemurafenib, cobimetinib and LDH as a predictive marker in BRAF-mutated melanoma

Debate: Do biomarkers 0:08:54

Debate: Do biomarkers have a role in the adjuvant setting? - No

Pathways of Resistance 0:05:36

Pathways of Resistance in Metastatic Colorectal Cancer

Personalized Medicine in 0:03:03

Personalized Medicine in Colorectal Cancer

Next-Generation Sequencing and 0:06:54

Next-Generation Sequencing and Molecular Subsets in Metastatic Colorectal Cancer

Impact of molecular 0:20:05

Impact of molecular subsets in colorectal cancer on adjuvant and advanced disease therapy

Predicting response to 0:04:44

Predicting response to immunotheapy

BRAF Testing in 0:04:44

BRAF Testing in Colorectal Cancer

Dr. Messersmith on 0:02:08

Dr. Messersmith on Choosing a Treatment Option in mCRC

A potential prognostic 0:02:35

A potential prognostic biomarker of chemoresistance in mCRC treated with FUFIRI or mIrOx (FIRE1)

Is broad NGS 0:11:35

Is broad NGS testing useful in patients with metastatic colorectal cancer? - Pro

Key Insights in 0:27:23

Key Insights in Colorectal Cancer

Evidence in BRAF-Mutant 0:03:42

Evidence in BRAF-Mutant CRC Tumors

Biomarker Assessment and 1:57:20

Biomarker Assessment and Related Treatment Decision-Making for Patients with Colorectal Cancer

How Tumor Sidedness 0:04:31

How Tumor Sidedness Now Influences Colorectal Cancer

GI Updates | 0:22:14

GI Updates | Axel Grothey, MD